{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:03Z","timestamp":1791412023782,"version":"4.3.3"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.autrev.2011.04.013","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T06:07:04Z","timestamp":1303711624000},"page":"624-630","source":"Crossref","is-referenced-by-count":69,"title":["B cells in systemic sclerosis: A possible target for therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"Silvia","family":"Bosello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigliola","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Ferraccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.04.013_bb0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"Gu","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1568-9972(03)00005-3","article-title":"Systemic sclerosis: current views of its pathogenesis","volume":"2","author":"Derk","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.013_bb0015","first-page":"53","article-title":"Hypothesis for the pathogenesis of systemic sclerosis","volume":"24","author":"Furst","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.013_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.013_bb0030","first-page":"59","article-title":"Polyclonal B lymphocyte activation in progressive systemic sclerosis","volume":"29","author":"Famularo","year":"1989","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0035","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0040","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.04.013_bb0050","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)63328-7","article-title":"B Lymphocyte signaling established by the CD19\/CD22 loop regulates autoimmunity in the tight-skin mouse","volume":"165","author":"Asano","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","article-title":"B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis","volume":"169","author":"Hasegawa","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.2008.095463","article-title":"Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.013_bb0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","article-title":"B cell depletion with Rituximab in patients with diffuse cutaneous systemic sclerosis","volume":"60","author":"Lafyatis","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0070","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2965","article-title":"B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in a thirty-six months follow-up-open label trial","volume":"12","author":"Bosello","year":"2010","journal-title":"Arthritis Res Therapy"},{"key":"10.1016\/j.autrev.2011.04.013_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.04.013_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semarthrit.2009.09.003","article-title":"Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature","volume":"40","author":"Daoussis","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0085","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/kem357","article-title":"Successful treatment of resistant scleroderma-associated interstitial lung disease with Rituximab","volume":"47","author":"McGonagle","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.04.013_bb0090","article-title":"Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with Rituximab","volume":"8","author":"Yoo","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.04.013_bb0095","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.jaad.2007.06.010","article-title":"Discordant response to Rituximab in a systemic sclerosis patient with associated myositis","volume":"58","author":"Fabri","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1346-8138.2009.00763.x","article-title":"B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis","volume":"37","author":"Hasegawa","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/BOR.0b013e32830c45ae","article-title":"T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis","volume":"20","author":"Chizzolini","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1 \u2044T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","article-title":"Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin-6","volume":"97","author":"Duncan","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0125","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.183.3.891","article-title":"B cells solicit their own help from T cells","volume":"83","author":"Stockinger","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1084\/jem.183.3.717","article-title":"The role of B cells in the programming of T cells for IL-4 synthesis","volume":"183","author":"Mason","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0140","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.4049\/jimmunol.163.8.4284","article-title":"Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development","volume":"163","author":"Skok","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4- producing CD4+ T cells","volume":"185","author":"Rincon","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0150","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1073\/pnas.89.13.6065","article-title":"Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell receptor transgenic system","volume":"89","author":"Hsieh","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.04.013_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","article-title":"The biology of interleukin-6","volume":"74","author":"Kishimoto","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.04.013_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0165","first-page":"308","article-title":"Serum levels of Interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis","volume":"25","author":"Hasegawa","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1465-9921-6-96","article-title":"Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis","volume":"6","author":"De Santis","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2011.04.013_bb0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"key":"10.1016\/j.autrev.2011.04.013_bb0180","first-page":"296","article-title":"Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts","volume":"25","author":"Kadono","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/cyto.2000.0822","article-title":"Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts","volume":"13","author":"Kondo","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2011.04.013_bb0190","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.4049\/jimmunol.151.9.4625","article-title":"Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro","volume":"151","author":"Snapper","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0195","first-page":"493","article-title":"Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton","volume":"82","author":"Green","year":"1976","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0200","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0952-7915(94)90016-7","article-title":"Autoantibodies in scleroderma and tight skin mice","volume":"6","author":"Bona","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0205","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/MCB.14.6.3884","article-title":"Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development","volume":"14","author":"Zhou","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0210","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/sj.jid.5700919","article-title":"BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice","volume":"127","author":"Matsushita","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0220","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0225","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL 10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molimm.2004.06.025","article-title":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis","volume":"41","author":"Sato","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0235","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/art.20674","article-title":"Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis","volume":"50","author":"Tsuchiya","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0039.2007.00801.x","article-title":"Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis","volume":"69","author":"Hitomi","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.04.013_bb0245","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/08830189909088489","article-title":"Expression and function of Fas during differentiation and activation of B cells","volume":"18","author":"Wang","year":"1999","journal-title":"Intern Rev Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0250","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.04.013_bb0255","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","article-title":"Alterations of mononuclear inflammatory cells, CD4\/CD8+ cells, interleukin-1\u03b2, and tumor necrosis factor-\u03b1 in the bronchoalveolar lavage fluid, pheripheral blood, and skin of patients with systemic sclerosis","volume":"58","author":"Hussein","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Krailing","year":"1995","journal-title":"Pathobiol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0265","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0270","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/j.1752-699X.2010.00228.x","article-title":"Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease","author":"De Santis","year":"2010","journal-title":"Clin Respir J"},{"key":"10.1016\/j.autrev.2011.04.013_bb0280","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.bor.0000245726.33006.c3","article-title":"Is scleroderma an autoantibody mediated disease?","volume":"18","author":"Arnett","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0285","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coi.2007.11.004","article-title":"Pathogenic autoantibodies in systemic sclerosis","volume":"19","author":"Gabrielli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2011.04.013_bb0290","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0295","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis","volume":"10","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0300","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0030002","article-title":"Antibodies againsthuman cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach","volume":"3","author":"Lunardi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0305","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.10362","article-title":"Antifibroblast antibodies from sistemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway","volume":"46","author":"Ronda","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.013_bb0310","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.04.013_bb0315","doi-asserted-by":"crossref","first-page":"36474","DOI":"10.1074\/jbc.M502851200","article-title":"PDGF and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1\/2. Amplification of ROS\u2013ERK\u2013Ras signalling in systemic sclerosis fibroblasts","volume":"280","author":"Svegliati","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2011.04.013_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2007.02.020","article-title":"Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets","volume":"7","author":"Gabrielli","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.013_bb0325","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V100.5.1602.h81702001602_1602_1610","article-title":"High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes","volume":"100","author":"McSweeney","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.04.013_bb0330","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14712598.3.7.1041","article-title":"Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders","volume":"3","author":"Tyndall","year":"2003","journal-title":"Expert Opin Biol Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T13:24:07Z","timestamp":1686057847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1568997211000814"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.04.013","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}